SCHEMBL7416867

SCHEMBL7416867

COc1ccc(S(=O)(=O)N[C@@H](Cc2ccc(OCCCONC(=N)N)cc2)C(=O)OC(=O)C(F)(F)F)cc1OC

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.40
ITGB3 P05106 7/20 0.40
ITGAV P06756 6/20 0.40
F2 P00734 5/20 0.39
PPARG P37231 1/20 0.38
KCNA5 P22460 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38
ITGA2B P08514 5/20 0.38
TMPRSS6 Q8IU80 4/20 0.38
MMP2 P08253 1/20 0.37
MMP9 P14780 1/20 0.37
ITGB1 P05556 1/20 0.37
ITGA5 P08648 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7694791 0.92 MMP2 (0.45) ITGB3ITGAVF2KCNA5ITGA2B
SCHEMBL7415180 0.90 CYP3A4 (0.45) ITGB3ITGAVPPARGCYP3A4CYP2C19
Trifluoroacetic Acid SCHEMBL7416863 0.90 ITGB3 (0.48) NPSR1ITGB3ITGAVF2PPARG
SCHEMBL7415235 0.89 KCNA5 (0.44) ITGB3ITGAVF2KCNA5ITGA2B
SCHEMBL7412728 0.89 F2 (0.39) ITGB3ITGAVF2ITGA2BTMPRSS6
SCHEMBL7416574 0.89 ITGB3 (0.45) ITGB3ITGAVF2KCNA5ITGA2B
SCHEMBL7419767 0.88 CYP3A4 (0.44) ITGB3ITGAVF2PPARGMEN1
SCHEMBL7417130 0.88 F2 (0.45) ITGB3F2ITGA2BTMPRSS6
SCHEMBL7415413 0.88 TMPRSS6 (0.38) ITGB3ITGAVF2ITGA2BTMPRSS6
SCHEMBL7415735 0.88 F2 (0.38) ITGB3ITGAVF2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6344484-B1 TREATMENT OF TUMOR GROWTH, METASTASIS, OSTEOPOROSIS, RESTENOSIS, INFLAMMATION, MACULAR DEGENERATION, DIABETIC RETINOPATHY, AND RHEUMATOID ARTHRITIS 3-DIMENSIONAL PHARMACEUTICALS, INC. 2002-02-05 US disclosed
EP-1159262-A1 TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2001-12-05 EP disclosed
WO-2000047552-A1 TYROSINE ALKOXYGUANIDINES AS INTEGRIN INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2000-08-17 WO disclosed